Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer: a Randomized Phase II Trial

NCT03280407 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT03280407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03280407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer: a Randomized Phase II Trial
Lead sponsor
Zealand University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2017
Completion date
December 31, 2024
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, colorectal cancer, colorectal neoplasm, intestinal disease, intestinal neoplasms, rectal cancer, rectal neoplasms